POTENTIAL

作品数:3519被引量:6314H指数:27
导出分析报告
相关领域:医药卫生更多>>
相关作者:韦峥姚泽恩王超牛彦徐萍更多>>
相关机构:北京大学复旦大学中国科学院上海交通大学更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划中国博士后科学基金国家教育部博士点基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=World Journal of Gastroenterologyx
条 记 录,以下是1-10
视图:
排序:
Tenofovir amibufenamide:A potential alternative for chronic hepatitis B treatment
《World Journal of Gastroenterology》2025年第10期139-143,共5页Hai-Nan Ma Kai-Sen Cao Yan-Miao Liu Cheng Chen Hang Zhang Fu-Shan Tang 
Tenofovir amibufenamide(TMF)is a novel prodrug of tenofovir that demonstrates a promising safety and efficacy profile.A recent study by Peng et al compared TMF with tenofovir alafenamide in the treatment of chronic he...
关键词:Tenofovir amibufenamide Tenofovir alafenamide Chronic hepatitis B Antiviral efficacy Safety profile HYPERLIPIDEMIA 
Herbal medicine as a potential treatment for non-alcoholic fatty liver disease
《World Journal of Gastroenterology》2025年第9期171-175,共5页Wen-Yi Nie Yang Ye Hong-Xuan Tong Jing-Qing Hu 
Non-alcoholic fatty liver disease(NAFLD)has emerged as a global public health concern,affecting over one-quarter of the global population.It is closely associated with the prevalence of obesity and metabolic syndrome....
关键词:AUTOPHAGY Fanlian Huazhuo Formula Herbal medicine Non-alcoholic fatty liver disease Traditional Chinese medicine 
Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease:A promising future
《World Journal of Gastroenterology》2024年第43期4597-4601,共5页Wen-Yige Zhang Meng-Hui Wang Chuan Xie 
Supported by National Natural Science Foundation of China,No.82100599 and No.81960112;Jiangxi Provincial Department of Science and Technology,No.20242BAB26122;Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine,No.2023Z021;Project of Jiangxi Provincial Academic and Technical Leaders Training Program for Major Disciplines,No.20243BCE51001.
In this editorial,we provide insights into the publication by Niu et al featured in the latest edition of the World Journal of Gastroenterology.Specifically,our focus was on exploring the potential of traditional Chin...
关键词:Nonalcoholic fatty liver disease Traditional Chinese medicine High-fat diet POTENTIAL PROSPECTS 
Lipid metabolism-related long noncoding RNAs:A potential prognostic biomarker for hepatocellular carcinoma
《World Journal of Gastroenterology》2024年第33期3799-3802,共4页Rui-Nan Zhang Jian-Gao Fan 
Supported by National Natural Science Foundation of China,No.82170593,No.81700503;the National Key Research and Development Program of China,No.2021YFC2700802.
The incidence rates of hepatocellular carcinoma(HCC)have increased in recent decades.Despite advancements in therapy and early diagnosis improving shortterm prognosis,long-term outcomes remain poor.Long noncoding RNAs...
关键词:Long noncoding RNAs Lipid metabolism Hepatocellular carcinoma PROGNOSIS BIOMARKER 
Harnessing autophagy: A potential breakthrough in digestive disease treatment
《World Journal of Gastroenterology》2024年第24期3036-3043,共8页Mukaddes Esrefoglu 
Autophagy,a conserved cellular degradation process,is crucial for various cellular processes such as immune responses,inflammation,metabolic and oxidative stress adaptation,cell proliferation,development,and tissue re...
关键词:AUTOPHAGY Digestive disease Inflammatory bowel disease Gastrointestinal cancer Harnessing autophagy 
Potential therapeutic targets for nonalcoholic fatty liver disease:Glucagon-like peptide 1被引量:2
《World Journal of Gastroenterology》2023年第48期6235-6238,共4页Yue-Hua Yin Li-Xuan Sang Bing Chang 
Nonalcoholic fatty liver disease(NAFLD)is the most rapidly growing contributor to liver mortality and morbidity.Hepatocellular injury in nonalcoholic steatohepatitis(NASH)is caused by an increase in metabolic substrat...
关键词:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Antidiabetic drugs Glucagon-like peptide 1 Semaglutide 
Non-coding RNAs:The potential biomarker or therapeutic target in hepatic ischemia-reperfusion injury
《World Journal of Gastroenterology》2023年第33期4927-4941,共15页Jia-Li Shao Li-Juan Wang Ji Xiao Jin-Feng Yang 
the National Natural Science Foundation of China,No.82070648;the Science and Technology Innovation Program of Hunan Province,No.2021SK4014.
Hepatic ischemia-reperfusion injury(HIRI)is the major complication of liver surgery and liver transplantation,that may increase the postoperative morbidity,mortality,tumor progression,and metastasis.The underlying mec...
关键词:Hepatic ischemia-reperfusion injury Non-coding RNAs MICRORNAS Long non-coding RNAs Circular RNAs 
Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease被引量:2
《World Journal of Gastroenterology》2023年第27期4252-4270,共19页Xiong-Quan Long Ming-Zhu Liu Zi-Hao Liu Lv-Zhou Xia Shi-Peng Lu Xiao-Ping Xu Ming-Hao Wu 
National Natural Science Foundation of China,No.81900466;and Hunan Provincial Natural Science Foundation of China,No.2020JJ5307.
Chronic and recurrent inflammatory disorders of the gastrointestinal tract caused by a complex interplay between genetics and intestinal dysbiosis are called inflammatory bowel disease.As a result of the interaction b...
关键词:Bile acids Inflammatory bowel disease Intestinal immunology Bile acid receptors Bile acid metabolism Gut microbiota 
Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments被引量:2
《World Journal of Gastroenterology》2023年第2期241-256,共16页Shu-Wu Zhao Yi-Ming Li Yi-Lin Li Chen Su 
the National Natural Science Foundation of China,No.81901141;the Scientific Research Project of Hunan Provincial Health Commission,No.202204114480.
The coronavirus disease 2019(COVID-19)pandemic has been a serious threat to global health for nearly 3 years.In addition to pulmonary complications,liver injury is not uncommon in patients with novel COVID-19.Although...
关键词:Liver injury COVID-19 Clinical feature Risk factor Treatment and management strategy 
Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value被引量:5
《World Journal of Gastroenterology》2022年第44期6213-6229,共17页Zhen-Jiao Li Hong-Zhong Gou Yu-Lin Zhang Xiao-Jing Song Lei Zhang 
Supported by the National Natural Science Foundation of China,No.31960236;the Talent Innovation and Entrepreneurship Project of Lanzhou City,No.2019-RC-34;the Lanzhou Cheng guan District Science and Technology Planning Project,No.2020SHFZ0029.
Primary sclerosing cholangitis(PSC)is an autoimmune disease characterized by chronic cholestasis,a persistent inflammation of the bile ducts that leads to sclerotic occlusion and cholestasis.Gut microbes,consisting of...
关键词:Primary sclerosing cholangitis Intestinal flora ANTIBIOTICS Fecal microbiota transplantation PROBIOTICS Bile acids 
检索报告 对象比较 聚类工具 使用帮助 返回顶部